Gables Capital Management’s Biogen BIIB Stock Holding History

Gables Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-30	Closed	-$6.47K	–	398
2024 Q1	$6.47K	Hold	30	–	–	﹤0.01%	341
2023 Q4	$7.76K	Hold	30	–	–	﹤0.01%	323
2023 Q3	$7.71K	Sell	30 -106	-78%	-$28.4K	0.01%	304
2023 Q2	$38.7K	Hold	136	–	–	0.03%	211
2023 Q1	$37.8K	Hold	136	–	–	0.03%	214
2022 Q4	$37.7K	Hold	136	–	–	0.03%	213
2022 Q3	$36K	Hold	136	–	–	0.03%	209
2022 Q2	$28K	Hold	136	–	–	0.02%	238
2022 Q1	$29K	Hold	136	–	–	0.02%	241
2021 Q4	$33K	Hold	136	–	–	0.02%	233
2021 Q3	$38K	Hold	136	–	–	0.02%	222
2021 Q2	$47K	Hold	136	–	–	0.03%	204
2021 Q1	$38K	Sell	136 -10	-7%	-$2.7K	0.02%	238
2020 Q4	$36K	Hold	146	–	–	0.02%	224
2020 Q3	$41K	Hold	146	–	–	0.03%	211
2020 Q2	$39K	Hold	146	–	–	0.03%	202
2020 Q1	$46K	Buy	146 +106	+265%	+$32.2K	0.04%	186
2019 Q4	$12K	Hold	40	–	–	0.01%	287
2019 Q3	$9K	Hold	40	–	–	0.01%	304
2019 Q2	$9K	Hold	40	–	–	0.01%	285
2019 Q1	$9K	Sell	40 -1,192	-97%	-$375K	0.01%	293
2018 Q4	$371K	Sell	1,232 -25	-2%	-$7.98K	0.32%	74
2018 Q3	$444K	Sell	1,257 -50	-4%	-$17.2K	0.34%	75
2018 Q2	$383K	Sell	1,307 -21	-2%	-$5.9K	0.31%	73
2018 Q1	$364K	Buy	+1,328	New	+$412K	0.32%	74

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Gables Capital Management's BIIB Position: Q2 2024 in Review

Gables Capital Management sold out of Biogen (BIIB) in Q2 2024, closing a stake of 30 shares — an estimated $6.47K sold.

Gables Capital Management first reported a position in BIIB in Q1 2018 and held it in 25 quarters. The position peaked at $444K in Q3 2018. 944 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

Gables Capital Management reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
Gables Capital Management sold 30 Biogen shares in Q2 2024, an estimated $6.47K.
Gables Capital Management first reported a position in Biogen in Q1 2018 and held it in 25 quarters.
Gables Capital Management's Biogen position peaked at $444K in Q3 2018.
944 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Gables Capital Management's 13F filing for Q2 2024, filed 8 Aug 2024.